ptau217 - Search News

News

A Groundbreaking Alzheimer's Blood Test Is Now FDA-Approved

People on MSN · 5h

FDA Clears First Blood Test to Diagnose Alzheimer’s Disease

The FDA greenlit marketing for the first blood test to help diagnose Alzheimer’s disease. Experts believe this will increase access to Alzheimer’s detection and reduce reliance on expensive PET scans and invasive spinal taps.

PhillyVoice · 1h

First-of-its-kind Alzheimer's blood test made by Malvern company gets FDA clearance

The blood test is used to detect abnormal protein deposits in the brain that are associated with Alzheimer's. The test is for people 55 and older who are already showing signs of the disease, according to a statement from the FDA. It is the first blood test of its kind to receive FDA clearance.

Flow Space on MSN · 5h

UPDATE: A Groundbreaking Alzheimer's Blood Test Is Now FDA-Approved

Possible to Get an Alzheimer’s Blood Test in Your Doctor’s Office. The FDA has just granted expedited approval for the Lumipulse G pTau217/ß-Amyloid 1-42 P

8h

A Blood Test for Alzheimer’s: What to Know

The test may make it easier to identify whether people with memory and thinking problems have Alzheimer’s or not.

Alamar Biosciences Expands NULISAseq™ CNS Disease Panel 120 with Groundbreaking Blood-Based Brain-Derived pTau Assays

Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, today announced the ...

4d

Statement from the Alzheimer's Drug Discovery Foundation (ADDF) on FDA Approval of the First Blood Test to Aid in Alzheimer's Diagnosis

Today, the FDA's approved the Lumipulse G pTau217/β-Amyloid 1-42 Plasma Ratio, marking a pivotal moment in the fight against ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results